Linkedin Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.

Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.

Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace Directory

Hematology analyzer, 9/13:76 (AACC)

Beckman Coulter’s UniCel DxH 600 Coulter cellular analysis system is for mid- to high-volume laboratories. The benchtop hematology analyzer—with advanced software—provides laboratories with exceptional quality results, improved first-pass accuracy, and automatic rerun and reflex testing, thereby reducing overall manual review rates and processes. The UniCel DxH 600 is equipped with software that saves time by allowing labs to partially release patient results manually or automatically via decision rules, enables users to create and edit decision rules during instrument operation, and

Data processing and storage system, 9/13:74 (AACC)

Beckman Coulter’s Remisol Advance data-management system, v1.7 streamlines laboratory workflow and the result management process by improving sample tracking and results archiving, and through consolidating patient test information from multiple instruments in the lab or from multiple labs in the hospital network. Remisol Advance v1.7 unifies data management and features a 166 percent increase in sample data processing throughput and a 122 percent increase in sample data storage over the previous version. The software improves results reporting turnaround times and

Automation solution and more, 9/13:74 (AACC)

Siemens Healthcare Diagnostics’ VersaCell X3 solution helps labs achieve the workflow benefits of automation without the space or budget considerations of a track-based solution. The platform connects up to three Siemens analyzers through one robotic sample interface, thus increasing productivity. By supporting a customized mix of chemistry, immunoassay, and/or integrated systems and associated assay menus, the VersaCell X3 solution helps labs reduce operator sample handling, prioritize staff work, and eliminate pre- and postanalytical processing—all through one-touch sample management. A priority

SeraCare Life Sciences goes live with SAP

SeraCare Life Sciences completed its implementation of SAP enterprise resource planning (ERP) software. The SAP system integrates the company’s inventory planning and control, purchasing, production management, quality management, and financial reporting systems into a single software solution.

Competency review software for EasyCell

Medica’s Competency Review software for its EasyCell assistant cell imaging system for hematology labs integrates evaluations of technologists into the laboratory’s daily routine. With the software, an instructor can train and evaluate the expertise of technologists in classifying white cells and red cell morphology.

TDM linearity and control materials with lithium, 9/13

Audit MicroControls received 510(k) clearance from the FDA, allowing the addition of assayed lithium to Audit’s therapeutic drug monitoring daily quality control and calibration verification/linearity kits. With the addition of lithium, Audit’s TDM linearity kit will have five levels and 14 assayed analytes and the control will have three levels and 13 assayed analytes.

Hemostasis testing system, 9/13:104

Diagnostica Stago expanded its line of automated hemostasis analyzers with the launch of the STA Compact Max Hemostasis Testing System, a coagulation testing solution for mid- to high-volume laboratories. The new touchscreen user interface enables intuitive operation at any skill level, and the system’s integrated expert module offers autoverification, expert rules, an advanced QC system, and electronic lot conversion.

PerFix reagent kits, 9/13

Beckman Coulter Life Sciences’ new reagent kits for intracellular staining minimize sample manipulation for a streamlined workflow. Developed for use on Beckman Coulter’s Gallios and Navios series flow cytometers and compatible with all Beckman fluorochromes, the kits enable a clear focus on the cytoplasmic and nuclear compartments of the cell.

Vitamin D assay, 9/13:103

Gold Standard Diagnostics announced FDA 510(k) clearance of its 25-OH vitamin D, total ELISA. This assay correlates with established liquid chromatography/mass spectrometry, enzyme immunoassay, and chemiluminescence methods, and offers high sensitivity and specificity over a wide dynamic range. The assay can be automated on a variety of instruments, providing a cost-effective vitamin D testing option even at lower volumes.

Real-time array technology for point-of-care testing, 9/13

Seegene’s novel real-time array technology is designed to accelerate the development of point-of-care testing by eliminating steps that normally follow PCR amplification, and that are required for conventional arrays. The new technology unifies all the steps into one. There is no size limitation for the PCR amplicon, and the array technology requires no asymmetric PCR, denaturation of the PCR amplicon, target specific primer extension, signal amplification, or washing step.

MARKETPLACE

TRENDING